For example, in non-small cell lung cancer (NSCLC), dysregulation of the Ras–Raf–MEK–ERK, PI3K/Akt, ERK, STAT3, and EGFR pathways has been implicated [for a recent review, see [7]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.